Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.
The precision medicine initiative will use real-world data from the Learning Health Network for clinical validation and refinement of cancer risk prediction models.
Cerner Collaboration to Increase Access to Cancer Clinical Trials streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.